Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy
about
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy
description
article
@en
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@en
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@nl
type
label
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@en
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@nl
prefLabel
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@en
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@nl
P2093
P1476
Retention Rate, Persistence an ...... gle-Center Experience in Italy
@en
P2093
Eleonora Scaioli
Elisa Liverani
Franco Bazzoli
Luigi Ricciardiello
Matteo Bellanova
P304
P356
10.1007/S10620-018-5329-4
P407
P577
2018-10-17T00:00:00Z